JP6116691B2 - 濃縮物質を含む容器及びその使用方法 - Google Patents

濃縮物質を含む容器及びその使用方法 Download PDF

Info

Publication number
JP6116691B2
JP6116691B2 JP2015530093A JP2015530093A JP6116691B2 JP 6116691 B2 JP6116691 B2 JP 6116691B2 JP 2015530093 A JP2015530093 A JP 2015530093A JP 2015530093 A JP2015530093 A JP 2015530093A JP 6116691 B2 JP6116691 B2 JP 6116691B2
Authority
JP
Japan
Prior art keywords
container body
contrast agent
concentrated
volume
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015530093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015528351A (ja
JP2015528351A5 (https=
Inventor
スコット ウェイン ホランダー
スコット ウェイン ホランダー
ジョエル ロバート ティンバーレイク
ジョエル ロバート ティンバーレイク
マージョリィ カダシュ
マージョリィ カダシュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of JP2015528351A publication Critical patent/JP2015528351A/ja
Publication of JP2015528351A5 publication Critical patent/JP2015528351A5/ja
Application granted granted Critical
Publication of JP6116691B2 publication Critical patent/JP6116691B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/54Inspection openings or windows
    • B65D25/56Inspection openings or windows with means for indicating level of contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015Devices specially adapted for taking medicines
    • A61J7/0046Cups, bottles or bags
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0404X-ray contrast preparations containing barium sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452Solutions, e.g. for injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A61K49/105Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A61K49/108Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/126Linear polymers, e.g. dextran, inulin, PEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
    • B65D85/804Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
    • B65D85/816Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package into which liquid is added and the resulting preparation is retained, e.g. cups preloaded with powder or dehydrated food
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01FMEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F19/00Calibrated capacity measures for fluids or fluent solid material, e.g. measuring cups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2015530093A 2012-08-30 2013-08-30 濃縮物質を含む容器及びその使用方法 Expired - Fee Related JP6116691B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/599,045 2012-08-30
US13/599,045 US20140065076A1 (en) 2012-08-30 2012-08-30 Container with concentrated substance and method of using the same
PCT/US2013/057529 WO2014036402A1 (en) 2012-08-30 2013-08-30 Container with concentrated substance and method of using the same

Publications (3)

Publication Number Publication Date
JP2015528351A JP2015528351A (ja) 2015-09-28
JP2015528351A5 JP2015528351A5 (https=) 2016-08-25
JP6116691B2 true JP6116691B2 (ja) 2017-04-19

Family

ID=49209541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530093A Expired - Fee Related JP6116691B2 (ja) 2012-08-30 2013-08-30 濃縮物質を含む容器及びその使用方法

Country Status (8)

Country Link
US (2) US20140065076A1 (https=)
EP (1) EP2890354B1 (https=)
JP (1) JP6116691B2 (https=)
CA (1) CA2883391C (https=)
ES (1) ES2592705T3 (https=)
RU (1) RU2646826C2 (https=)
TW (1) TWI581787B (https=)
WO (1) WO2014036402A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015224847C1 (en) * 2014-03-04 2021-03-04 Otsuka Pharmaceutical Co., Ltd. Iohexol powder and method of using the same
US20160060022A1 (en) * 2014-08-27 2016-03-03 John Frank Stagl Apparatus for providing cocktail mix
US11090130B2 (en) * 2015-10-09 2021-08-17 Oregon State University Fiducial marker for computed tomography and magnetic resonance imaging
GB201703227D0 (en) * 2017-01-20 2017-04-12 Ge Healthcare As Plastic containers
US10947012B1 (en) * 2019-04-23 2021-03-16 Express Scripts Strategic Development, Inc. Container with fill gauge
RU2715386C1 (ru) * 2019-04-26 2020-02-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Упаковка для мягкой лекарственной формы индивидуального изготовления
EA202193251A1 (ru) 2019-06-05 2022-03-10 Эмори Юниверсити Пептидомиметики для лечения коронавирусной и пикорнавирусной инфекций
JP7444554B2 (ja) * 2019-06-21 2024-03-06 大和製罐株式会社 難溶性飲料製品
CN110559188A (zh) * 2019-09-17 2019-12-13 长沙凯泽工程设计有限公司 一种药物提取装置
KR102523963B1 (ko) * 2020-01-03 2023-04-21 이화여자대학교 산학협력단 이종 약물을 혼합하기 위한 안약 용기
JP1698883S (https=) 2020-05-15 2021-11-08
GB2601578A (en) * 2020-05-15 2022-06-08 Procter & Gamble Refillable product containing dissolvable solid article
CA3117023A1 (en) * 2020-05-15 2021-11-15 The Procter & Gamble Company Product containing dissolvable solid article
WO2021236322A1 (en) * 2020-05-19 2021-11-25 Exxonmobil Chemical Patents Inc. Extrusion blow molded containers and processes for making same
JP7614333B2 (ja) 2020-09-10 2025-01-15 ザ プロクター アンド ギャンブル カンパニー 抗細菌活性物質を含有する溶解性固体物品
CN116761578A (zh) 2021-01-21 2023-09-15 宝洁公司 含有防腐剂的可溶性固体制品
CN113069129B (zh) * 2021-02-26 2023-04-11 四川省肿瘤医院 一种18f-fdg pet/ct检查去除胃内伪影的方法
CA3227354A1 (en) 2021-08-20 2023-02-23 The Procter & Gamble Company Dissolvable solid article containing silicone

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127881C (https=) * 1963-03-25
FR2298840A1 (fr) * 1975-01-22 1976-08-20 Beaudoux Maurice Etiquette pour recipient transparent ou translucide contenant un produit a doser
DE3776020D1 (en) * 1986-07-15 1992-02-27 Fausto Spoleto It Gallina Container administering barium sulphate suspension and air
JPH0674213B2 (ja) * 1988-07-05 1994-09-21 マナック株式会社 消化管用固形x線造影剤
JPH02261801A (ja) * 1989-04-03 1990-10-24 Tetsuo Suami 低粘度ヨード化ヒドロキシエチル澱粉およびその製法
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
JPH0734816B2 (ja) * 1991-06-26 1995-04-19 新田ゼラチン株式会社 医科用および歯科用硬化性材料
CA2133861C (en) * 1993-10-11 2004-03-30 Peter Koltringer Preparation for the treatment of circulatory changes
MY132225A (en) * 1995-03-13 2007-09-28 Amersham Health Inc Contrast agent for ultrasonography
US5847212A (en) * 1997-04-21 1998-12-08 Abbott Laboratories Process for the preparation of iohexol
JP3559966B2 (ja) * 2001-07-11 2004-09-02 堀井薬品工業株式会社 注腸造影法に用いる造影剤容器
WO2004014739A2 (en) * 2002-08-08 2004-02-19 Concept & Design Ltd. A portable beverage preparation device and system
NO20033058D0 (no) * 2003-07-03 2003-07-03 Amersham Health As Prosess
CN100344322C (zh) * 2004-05-27 2007-10-24 姜叶东 治疗心脏病的药物及其制备方法
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB2435027A (en) * 2006-02-08 2007-08-15 Shurbhi Shah Container for use in administering medicine
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
US20080044314A1 (en) * 2006-06-23 2008-02-21 Cephalon, Inc. Pharmaceutical measuring and dispensing cup
KR20080035926A (ko) * 2006-10-20 2008-04-24 재단법인서울대학교산학협력재단 자성체 나노입자를 함유한 코어-외각 구조의 금 나노입자의자기공명영상의 티2 조영제, 암 진단제 및 암치료제로서의 용도
US7674434B2 (en) * 2006-11-27 2010-03-09 Cytyc Corporation Vials and apparatus for obtaining an aliquot of a sample
KR101018221B1 (ko) * 2008-05-16 2011-02-28 한남대학교 산학협력단 금-증착된 산화철/글리콜 키토산 복합체, 이의 제조방법 및 이를 포함하는 mri 조영제
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
US9403624B2 (en) * 2009-08-24 2016-08-02 Beekley Corporation Device and method for dispensing a beverage and imaging contrast agent
JP2013126429A (ja) * 2010-03-29 2013-06-27 Morimoto Iyaku:Kk 医薬組成物容器
CN202223624U (zh) * 2011-08-31 2012-05-23 郑培省 调压洗肠器
CN102580120B (zh) * 2012-03-21 2014-04-02 海南医学院附属医院 一种靶向性mri对比剂及其制备方法

Also Published As

Publication number Publication date
EP2890354B1 (en) 2016-07-20
CA2883391C (en) 2020-12-29
TWI581787B (zh) 2017-05-11
US20140065076A1 (en) 2014-03-06
EP2890354A1 (en) 2015-07-08
WO2014036402A1 (en) 2014-03-06
RU2015111256A (ru) 2016-10-20
RU2646826C2 (ru) 2018-03-07
JP2015528351A (ja) 2015-09-28
ES2592705T3 (es) 2016-12-01
US20140065077A1 (en) 2014-03-06
TW201410232A (zh) 2014-03-16
CA2883391A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
JP6116691B2 (ja) 濃縮物質を含む容器及びその使用方法
US10898515B2 (en) Colon lavage system
CN105963701A (zh) 用于肠道清洁的方法、组合物以及包装
EP2626085A1 (en) Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging digestive tract
NO312177B1 (no) Pakke klar for oral administrasjon
JPH03206046A (ja) 腸管洗浄液用組成物及び腸管洗浄液
JP6441678B2 (ja) Ctコロノグラフィに用いられる経口投与用液剤及び消化管造影用組成物
US20130052143A1 (en) Liquid preparation for oral administration to be used in ct colonography, and composition for digestive tract imaging
US20200352855A1 (en) Colon Cleansing Composition and Methods of Using Same
US20050180920A1 (en) Oral contrast media composition for computerized axial tomographic examinations and method
US12433914B2 (en) Methods of administering safe colon cleansing compositions
US20240325436A1 (en) Safe Flavoring Composition to Improve Compliance in Colon Cleansing Compositions
HK1167572A (en) Colon lavage system
HK1167572B (en) Colon lavage system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160705

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20160705

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20160818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161018

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170215

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170321

R150 Certificate of patent or registration of utility model

Ref document number: 6116691

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees